Regulations.gov document
Labeling Requirements for Approved or Conditionally Approved New Animal Drugs; Extension…
Proposed Rule · FDA-2023-N-5160 · posted May 22, 2024
Key facts
| Document ID | FDA-2023-N-5160-0011 |
|---|---|
| Title | Labeling Requirements for Approved or Conditionally Approved New Animal Drugs; Extension of Comment Period |
| Document type | Proposed Rule |
| Subtype | Extension of Comment Period |
| Agency | FDA |
| Docket | FDA-2023-N-5160 |
| Posted | May 22, 2024 |
| Federal Register citation | 89 FR 44944 |
| FR document number | 2024-11229 |
| CFR | 21 CFR Parts 201, 500, 501, 510, 514, and 516 |
| Comment period opens | May 22, 2024 |
| Effective date | May 22, 2024 |
At a glance
- 1–9 Pages
- 10–99 Public comments on this docket
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About Regulations.gov documents
Regulations.gov holds the rulemaking and other documents federal agencies post for public comment. Only agency documents are published here; public submissions are not.
Source: Regulations.gov (U.S. General Services Administration eRulemaking Program) · Source date: